Foreword (K. M. Richter) Preface (M. Sticherling, E. Christophers) Definitive T cell epitope mapping for a human disease: gluten challenge in coeliac disease identifies a dominant transglutaminase-deamidated T cell epitope (Robert P. Anderson) On the extrapolation from animal models to human disease for the design of immunotherapy in autoimmune diabetes (Jean-F. Bach) Use of olfactory ensheathing cells as candidates for transplant-mediated repair of central nervous system lesions (Susan C. Barnett) Advances in understanding and use of autoantibodies as markers of diseases (Marvin J. Fritzler, Leeanne J. Schoenroth) Leflunomide therapy for autoimmune diseases (Angela Gause, Claudia Metzler, Eva Reinhold-Keller, Wolfgang L. Gross) Immunotherapy for ocular inflammatory disease (Kathrin H. Greiner, John V. Forrester) Advances in immunosuppressive treatment of juvenile idiopathic arthritis (Gerd Horneff) Significance of gamma-delta T lymphocytes in autoimmune diseases (Dieter Kabelitz) Treatment of autoimmune diseases by targeted DNA vaccines encoding proinflammatory mediators (Nathan Karin) Immunosuppressive treatment of rheumatic diseases during pregnancy (Monika Østensen) Persistence of maternal and fetal cells in autoimmune diseases (Anne M. Stevens, J. Lee Nelson, Nathalie Lambert) Therapeutic aspects of autoimmune diseases of the skin (Michael Sticherling) Long-term effects of T cell vaccination in multiple sclerosis (Piet Stinissen, Guy Hermans, Niels Hellings, Robert Medaer, Jef Raus) Plasmid-mediated delivery of antigens or biological response modifiers as means to suppress autoimmunity (Matthias von Herrath, Adrian Bot) Intravenous immunoglobulins for the treatment of childhood autoimmune diseases (Volker Wahn)